Study shows certain gastrointestinal tumors associated with higher mortality

April 5, 2016, University of California - San Diego
Study shows certain gastrointestinal tumors associated with higher mortality
Jason Sicklick, MD, surgical oncologist at UC San Diego Health. Credit: UC San Diego Health

Researchers at University of California, San Diego School of Medicine have determined that certain gastrointestinal stromal tumors (GISTs) are more deadly than previously reported in medical literature. Findings are published online in the Journal of Gastrointestinal Surgery.

"While GISTs are rare, we have found that certain groups of these tumors result in a much higher mortality than expected," said Jason Sicklick, MD, assistant professor of surgery at UC San Diego School of Medicine and a at UC San Diego Health. "The 5-year mortality rate for malignant GISTs of less than 2 centimeters is 12.1 percent. This finding may be helpful in creating new guidelines for the treatment of these tumors."

GISTs are most commonly found in the stomach and small intestine and have significant variability in terms of size and malignant behavior. Sicklick noted that up to 30 percent of patients have GISTs less than 2 centimeters in size, or slightly more than one-half inch. More than 79 percent of patients have localized , while 11.4 percent have regional or distant metastatic disease. Previously, researchers did not expect any disease to have spread.

"For this study, we identified 378 patients with malignant GISTs of less than 2 cm between 2001 and 2011 from the SEER database," said Taylor M. Coe, first author and fourth-year medical student at UC San Diego School of Medicine. "While the distribution of disease was almost equal between men and women, African-Americans are 2.1 times more likely than Caucasians to develop GISTs. The reasons are unknown and need to be further evaluated."

Sicklick added that further studies are needed to develop novel risk assessments for with these small tumors and to determine appropriate indications for surgery and/or medical therapy.

Explore further: New at-risk group identified for gastrointestinal stromal tumors

Related Stories

New at-risk group identified for gastrointestinal stromal tumors

October 7, 2014
Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach ...

Patients with gastrointestinal tumors at higher risk of other cancers

May 1, 2015
Researchers at UC San Diego School of Medicine conducted the first population-based study that characterizes the association and temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The ...

Use of new systemic adjuvant therapy in gastrointestinal tumors increasing

March 2, 2015
A new study finds that the use of adjuvant systemic therapy for localized gastrointestinal stromal tumors (GISTs ) has significantly increased over time and that patients treated with the therapy have better survival than ...

Underappreciated cause of bowel obstruction should be included in surgical assessments

May 6, 2015
Each year, more than 10 million Americans seek medical attention, often in emergency situations, for symptoms of intestinal blockages. Researchers at the University California, San Diego School of Medicine have identified ...

New technology spots drugs' early impact on cancer

April 9, 2013
A new preclinical technology enables researchers to quickly determine if a particular treatment is effective against gastrointestinal stromal tumors (GISTs), providing a boost to animal research and possibly patient care, ...

Recommended for you

'Liquid biopsy' predicts lymphoma therapy success within days, study finds

August 20, 2018
A blood test can predict which patients with a type of cancer called diffuse large B cell lymphoma are likely to respond positively to initial therapy and which are likely to need more aggressive treatment, according to a ...

Study shows how to make (and destroy) a metastatic cancer cell

August 20, 2018
Many cancers become especially dangerous only when they metastasize from their site of origin to faraway tissues such as lung, brain or bone. Now, a University of Colorado Cancer Center study published today in the Proceedings ...

Research team develops predictor for immunotherapy response in melanoma

August 20, 2018
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a novel type of immunotherapy. ...

Study details effect of radiation exposure on hormone deficiencies

August 20, 2018
In a new study, University of Cincinnati (UC) researchers, in collaboration with Massachusetts General Hospital, have detailed the effect of radiation exposure on the development of hormone deficiency in pediatric and young ...

Scientists discover new method of diagnosing cancer with malaria protein

August 17, 2018
In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilising a particular malaria protein that sticks to cancer ...

Researchers find pathways that uncover insight into development of lung cancer

August 17, 2018
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants. One of these genetic components, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.